Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,007.30 -25.84 -0.20%
Hang Seng 21,225.90 -0.02 0.00%
S&P/ASX 200 4,814.35 -11.53 -0.24%
  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARCA Biopharma Inc

+ Add to Watchlist

ABIO:US

1.3600 USD 0.0200 1.45%

As of 17:20:00 ET on 06/18/2013.

Company Profile for ARCA Biopharma Inc (ABIO)

Arca Biopharma, Inc. develops genetically targeted therapies for heart failure and other cardiovascular diseases.

Contact Information

ARCA Biopharma Inc

8001 Arista Place
Suite 200
Broomfield, CO 80021
United States
Phone: 1-720-940-2200

Key Executives for ARCA Biopharma Inc (ABIO)

Michael R BristowPresident/CEOPatrick M WheelerChief Financial Officer
Christopher D OzeroffSenior VP/Secretary/Gen Cnsl

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil